MRVI vs CDTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

MRVI

52.2
AI Score
VS
MRVI Wins

CDTX

49.9
AI Score

Investment Advisor Scores

MRVI

52score
Recommendation
HOLD

CDTX

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MRVI CDTX Winner
Forward P/E 370.3704 5.7504 CDTX
PEG Ratio 0 0 Tie
Revenue Growth 8.5% -100.0% MRVI
Earnings Growth -32.7% 0.0% CDTX
Tradestie Score 52.2/100 49.9/100 MRVI
Profit Margin -37.1% 0.0% CDTX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

MRVI 1M: +1.5% · 3M: +7.4% CDTX 1M: +0.3% · 3M: +117.1%

Current Technical Phase

MRVI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.1% over 20 days), RSI 54

RSI (14): 54.4 · Price: $7.57

CDTX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (34.6% over 20 days), RSI 85

RSI (14): 84.6 · Price: $221.38

Fundamentals Snapshot

Metric MRVI CDTX
Market Cap — —
Forward P/E -75.2 -35.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% -1.0%
Gross Margin 0.4% —
Operating Margin -0.3% 0.0%
EPS -0.53 -11.22
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MRVI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.